These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26353875)

  • 1. Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial.
    Milstone AM; Koontz DW; Voskertchian A; Popoola VO; Harrelson K; Ross T; Aucott SW; Gilmore MM; Carroll KC; Colantuoni E
    BMJ Open; 2015 Sep; 5(9):e009274. PubMed ID: 26353875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Treating Parents Colonized With Staphylococcus aureus on Transmission to Neonates in the Intensive Care Unit: A Randomized Clinical Trial.
    Milstone AM; Voskertchian A; Koontz DW; Khamash DF; Ross T; Aucott SW; Gilmore MM; Cosgrove SE; Carroll KC; Colantuoni E
    JAMA; 2020 Jan; 323(4):319-328. PubMed ID: 31886828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU.
    Akinboyo IC; Voskertchian A; Gorfu G; Betz JF; Ross TL; Carroll KC; Milstone AM
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1334-1339. PubMed ID: 30226122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients.
    Ridenour G; Lampen R; Federspiel J; Kritchevsky S; Wong E; Climo M
    Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1155-61. PubMed ID: 17828692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents.
    Watanakunakorn C; Axelson C; Bota B; Stahl C
    Am J Infect Control; 1995 Oct; 23(5):306-9. PubMed ID: 8585642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial.
    Wendt C; Schinke S; Württemberger M; Oberdorfer K; Bock-Hensley O; von Baum H
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1036-43. PubMed ID: 17932823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
    Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
    Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge.
    Reich PJ; Boyle MG; Hogan PG; Johnson AJ; Wallace MA; Elward AM; Warner BB; Burnham CA; Fritz SA
    Clin Microbiol Infect; 2016 Jul; 22(7):645.e1-8. PubMed ID: 27126609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit.
    Popoola VO; Colantuoni E; Suwantarat N; Pierce R; Carroll KC; Aucott SW; Milstone AM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):381-7. PubMed ID: 26725699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.
    Huang SS; Septimus E; Kleinman K; Moody J; Hickok J; Heim L; Gombosev A; Avery TR; Haffenreffer K; Shimelman L; Hayden MK; Weinstein RA; Spencer-Smith C; Kaganov RE; Murphy MV; Forehand T; Lankiewicz J; Coady MH; Portillo L; Sarup-Patel J; Jernigan JA; Perlin JB; Platt R;
    Lancet; 2019 Mar; 393(10177):1205-1215. PubMed ID: 30850112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Placebo-Controlled Trial of Topical Mupirocin to Reduce Staphylococcus aureus Colonization in Infants in the Neonatal Intensive Care Unit.
    Nelson MU; Shaw J; Gross SJ
    J Pediatr; 2021 Sep; 236():70-77. PubMed ID: 34023342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
    Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
    Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
    BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates.
    Delaney HM; Wang E; Melish M
    J Perinatol; 2013 Apr; 33(4):313-8. PubMed ID: 22918547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mupirocin decolonization on subsequent methicillin-resistant Staphylococcus aureus infection in infants in neonatal intensive care units.
    Huang YC; Lien RI; Lin TY
    Pediatr Infect Dis J; 2015 Mar; 34(3):241-5. PubMed ID: 25742074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery.
    Konvalinka A; Errett L; Fong IW
    J Hosp Infect; 2006 Oct; 64(2):162-8. PubMed ID: 16930768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.
    Fritz SA; Camins BC; Eisenstein KA; Fritz JM; Epplin EK; Burnham CA; Dukes J; Storch GA
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):872-80. PubMed ID: 21828967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
    Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
    J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of active surveillance and decolonization strategies for methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.
    Gollerkeri S; Oliver C; Maria M; Green DA; Wu F; Paul AA; Hill-Ricciuti A; Mathema B; Sahni R; Saiman L
    J Perinatol; 2024 May; 44(5):724-730. PubMed ID: 38351274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.